SEMABIZ, Inc.

自宅用採血キット市場 – 2029年までの世界予測

At-home Blood Collection Devices Market – Global Forecast to 2029

自宅用採血キット市場 – 製品（ランセット、DBSキット）、サンプルタイプ（液体、乾燥）、採取方法（プッシュボタン、レーザー）、デバイスタイプ（セルフ、プロフェッショナル）、用途（診断、スクリーニング、臨床試験） – 2029年までの世界予測
At-Home Blood Collection Devices Market by Product (Lancets, DBS Kits), Sample Type (Liquid, Dried), Collection Method (Push-button, Laser), Device Type (Self, Professional), Application (Diagnostics, Screening, Clinical Trials) – Global Forecast to 2029

The valuation of the at-home blood collection devices market in 2024 is USD 93 million and this market is projected to reach USD 135 million by 2029, growing at a CAGR of 7.6% for the period from 2024 to 2029.

2024 年の家庭用採血装置市場の評価額は 9,300 万ドルで、この市場は 2029 年までに 1 億 3,500 万ドルに達すると予測され 2024年から 2029 年までの期間は 7.6% の CAGR で成長します。

High demand for at-home blood collection & microsampling devices is primarily on account of rising infectious diseases, chronic disorders, and lifestyle-related diseases.

自宅用採血キット市場 – 2029年までの世界予測
At-home Blood Collection Devices Market – ecosystem

The key players in this market are Trajan Group Holdings Limited (Australia), Tasso, Inc. (US), YourBio Health, Inc. (US), A. Menarini Diagnostics (UK), R-Biopharm AG (Germany), Sussex Pathology Limited (UK), ImmunoServ (UK), Labonovum (Netherlands), Alpha Laboratories (UK), Lipomic Healthcare (India), Tri-Tech Forensics (US), RDA Spot Inc (Lithuania), Spot On Sciences (US), Capitainer (Sweden), PanoHealth (US), Lameditech (South Korea), Sara Healthcare (India), Owen Mumford Ltd (UK), RedDrop Dx, Inc. (US), AdvaCare Pharma (US), Naulakha Industries (India), and Phoenix Healthcare Solutions, LLC (US).

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing burden of chronic disorders and lifestyle-related health conditions, Increasing prevalence of infectious diseases, Rising geriatric population and incidence of age-associated diseases, and Rising demand for painless devices and growing technological advancements), opportunities (Growth opportunities in emerging economies), restraints (Unregulated use of products for at-home blood collection and Pricing pressure owing to reimbursement cuts and budget constraints), and challenges (Inadequate access to microsampling devices in resource-limited areas) influencing the growth of the at-home blood collection devices market market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the at-home blood collection devices market market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the at-home blood collection devices market market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the at-home blood collection devices market market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Tasso, Inc. (US), Trajan Group Holdings Limited (Australia), YourBio Health, Inc. (US), Capitainer (Sweden), and A. Menarini Diagnostics s.r.l (UK).

医療・医薬の最新記事8件